News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Polaris Management Co. VII, L.L.C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
SC 13D/A
| Polaris Management Co. VII, L.L.C. reports a 11.4% stake in SQZ BIOTECHNOLOGIES COMPANY |
| 11/13/2020 |
SC 13D
| Polaris Management Co. VII, L.L.C. reports a 13.4% stake in SQZ BIOTECHNOLOGIES COMPANY |
| 11/03/2020 |
4
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Converted 161,994 shares
@ $0
Converted 2,315,652 shares
@ $0
Bought 16,346 shares
@ $16, valued at
$261.5k
Bought 233,654 shares
@ $16, valued at
$3.7M
Converted 28,863 convertible preferred
@ $0
Converted 412,608 convertible preferred
@ $0
Converted 56,462 convertible preferred
@ $0
Converted 807,096 convertible preferred
@ $0
Converted 44,120 convertible preferred
@ $0
Converted 630,672 convertible preferred
@ $0
Converted 24,397 convertible preferred
@ $0 |
|
| 10/29/2020 |
3
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 3 on SQZ Biotechnologies Co |
| 09/22/2020 |
4
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Bought 214,962 shares
@ $13, valued at
$2.8M
Bought 15,038 shares
@ $13, valued at
$195.5k
Converted 1,832,582 shares
@ $0
Converted 128,201 shares
@ $0
Converted 451,666 shares
@ $0
Converted 20,585 shares
@ $0
Converted 216,106 shares
@ $0
Converted 15,118 shares
@ $0
Converted 1,832,582 convertible preferred
@ $0
Converted 128,201 convertible preferred
@ $0
Converted 451,666 convertible preferred
@ $0 |
|
| 09/15/2020 |
3
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 3 on Metacrine, Inc. |
| 07/07/2016 |
4
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Converted 1,164,486 shares
@ $0
Converted 22,167 shares
@ $0
Bought 373,847 shares
@ $12.5, valued at
$4.7M
Bought 26,153 shares
@ $12.5, valued at
$326.9k
Converted 4,366,825 preferred shares
@ $0
Converted 83,129 preferred shares
@ $0 |
|
| 06/29/2016 |
3
| Polaris Management Co. VII, L.L.C. (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
|
|